Price
No data yet.
Social Signal Score
Revenue
$2.11MAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Wayne Geoffrey Paterson
- Sector
- Healthcare
- Industry
- Medical - Devices
- Beta
- 0.75
- Country
- AU
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -4.77
Financials
Revenue
$2.11M-37.5%Net Income
$-66.62MEBITDA
$-66.95MFree Cash Flow
$0.00EPS (diluted)
$-3.02Shares Outstanding (diluted)
22.05M+29464.8%Operating Expenses
$69.10MCash & Debt
$113.84MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $4.37M | $-123.26M | $-6.09 |
| 2023 | $4.01M | $-67.33M | $-4.31 |
| 2022 | $4.59M | $-44.34M | $-3.32 |
| 2021 | $7.79M | $-22.91M | $-3.09 |
| 2020 | $7.08M | $-15.27M | $-2.58 |
| 2019 | $17.08M | $-5.82M | $-0.99 |
| 2018 | $25.60M | $-24.22M | $-7.93 |
| 2017 | $22.61M | $-17.26M | $-6.78 |
| 2016 | $22.32M | $-12.31M | $-4.90 |
| 2015 | $14.15M | $-24.01M | $-12.58 |
| 2014 | $10.13M | $-25.25M | $-16.48 |
| 2013 | $7.90M | $-6.62M | $-5.44 |
| 2012 | $7.40M | $-1.89M | $-2.05 |
| 2011 | $6.44M | $-10.00M | $-14.84 |
Valuation
AMEUFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+25.00%Social Signal Score
Mentions (2)
- Newsglobenewswire.com·35d ago·Neutral
Anteris to Present at September Healthcare Investor Conferences MINNEAPOLIS and BRISBANE, Australia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, is pleased to advise that Vice Chairman and Chief Executive Officer, Wayne Paterson, will be presenting at the Cantor Global Healt
View source ↗ - Newsglobenewswire.com·55d ago·Negative
Anteris Technologies Announces Results for the Second Quarter of 2026 MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended June 30, 2026, and provided a corporate update. Q2 2026 Highlights Se
View source ↗
Earnings
Typical surprise -83.4% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Oct 31$-1.83 vs $-1.00miss
Estimates and results for AMEUF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
No disclosed congressional trades in AMEUF.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.